Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study

Mia Vicki Fangel; Peter Brønnum Nielsen; Torben Bjerregaard Larsen; Bo Christensen; Thure Filskov Overvad; Professor Gregory Lip; Samuel Z. Goldhaber; Martin Bach Jensen

doi:10.1016/j.ijcard.2018.05.037

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2018

P1892Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: a nationwide cohort study

Mia Vicki Fangel, Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Bo Christensen, Thure Filskov Overvad, Professor Gregory Lip, Samuel Z. Goldhaber, Martin Bach Jensen

Article2019

Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus

Mia Vicki Fangel, Peter Brønnum Nielsen, Jette Kolding Kristensen, Torben Bjerregaard Larsen, Thure Filskov Overvad, Professor Gregory Lip, Martin Bach Jensen

Article2020

Thromboembolic events and major bleeding in frail patients with incident atrial fibrillation: a nationwide cohort study

Anette Arbjerg Højen, M Soegaard, Peter Brønnum Nielsen, F Skjoeth, Craig I Coleman, Professor Gregory Lip, Torben Bjerregaard Larsen

Article2020

High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study

Hyun‐Jung Lee, Eue-Keun Choi, Kyungdo Han, Dahye Kim, Euijae Lee, So-Ryoung Lee, Seil Oh, Professor Gregory Lip

Article2022

Oral anti‐coagulant treatment patterns in atrial fibrillation patients diagnosed with cancer: A Danish nationwide cohort study

Anne Gulbech Ording, Mette Søgaard, Peter Brønnum Nielsen, Professor Gregory Lip, Torben Bjerregaard Larsen, Erik Lerkevang Grove, Flemming Skjøth